Linear basal cell carcinoma: a distinct clinical entity in the periocular region
- PMID: 16406534
- DOI: 10.1016/j.ophtha.2005.04.035
Linear basal cell carcinoma: a distinct clinical entity in the periocular region
Abstract
Purpose: To report periocular linear basal cell carcinoma (BCC) as a distinct clinical entity, and to highlight its existence in the ophthalmic literature.
Design: Retrospective, noncomparative, multicenter, interventional small case series.
Participants: Four patients with linear BCC in the periocular region.
Intervention: All patients underwent margin-controlled excision, 3 utilizing Mohs' micrographic surgery and 1 using frozen section.
Main outcome measures: Age, gender, location, preoperative tumor size, histological growth pattern, presence of perineural invasion, number of Mohs' levels used to obtain histologic clearance, postoperative defect size, and recurrence.
Results: In all 4 cases, the site of occurrence was in the lower eyelid and cheek. Histology revealed pigmented nodular BCC with an infiltrative component in 2 cases and nodular BCC in the remaining 2 cases. No perineural invasion was noted in any of the cases. Two Mohs' levels were required for complete excision in 3 patients.
Conclusions: Linear BCC is a distinct clinical entity. Presence of the tumor along relaxing skin tension lines, increase in subclinical extension, and aggressive tumor behavior are reported observations. Because of these observations, it is suggested that margin-controlled excision should be considered for linear BCC.
Similar articles
-
The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.Ophthalmology. 2004 Apr;111(4):624-30. doi: 10.1016/j.ophtha.2003.12.003. Ophthalmology. 2004. PMID: 15051192
-
The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.Ophthalmology. 2004 Apr;111(4):631-6. doi: 10.1016/j.ophtha.2003.11.004. Ophthalmology. 2004. PMID: 15051193
-
Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.J Am Acad Dermatol. 2005 Sep;53(3):445-51. doi: 10.1016/j.jaad.2005.04.083. J Am Acad Dermatol. 2005. PMID: 16112351
-
Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.Br J Dermatol. 2004 Jul;151(1):141-7. doi: 10.1111/j.1365-2133.2004.06047.x. Br J Dermatol. 2004. PMID: 15270883 Review.
-
Linear basal cell carcinoma: A distinct clinical entity.J Plast Reconstr Aesthet Surg. 2006;59(4):419-23. doi: 10.1016/j.bjps.2005.09.039. J Plast Reconstr Aesthet Surg. 2006. PMID: 16756260 Review.
Cited by
-
Linear basal cell carcinoma of the lower eyelid: Reconstruction with a musculocutaneous transposition flap.JAAD Case Rep. 2018 Jul 20;4(7):633-635. doi: 10.1016/j.jdcr.2018.03.001. eCollection 2018 Aug. JAAD Case Rep. 2018. PMID: 30094304 Free PMC article. No abstract available.
-
Linear Basal cell carcinoma in an asian patient.Open Ophthalmol J. 2007 Dec 17;1:20-2. doi: 10.2174/1874364100701010020. Open Ophthalmol J. 2007. PMID: 19478861 Free PMC article.
-
A Systematic Review and Meta-Analysis of Ocular and Periocular Basal Cell Carcinoma with First-Time Description of Dermoscopic and Reflectance Confocal Microscopy Features of Caruncle Basal Cell Carcinoma.Diagnostics (Basel). 2025 May 14;15(10):1244. doi: 10.3390/diagnostics15101244. Diagnostics (Basel). 2025. PMID: 40428237 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical